Navigation Links
Advent of New, More Effective and Personalized Medicines

osely with industry and the healthcare community.

In addition to announcing the availability of its final guidance and the new pharmacogenomic Web page, the agency also reminded the public of the meeting being held on pharmacogenomics issues.

The joint FDA/DIA meeting, "Pharmacogenomics in Drug Development and Regulatory Decision Making” will focus on integrating pharmacogenomics in clinical trials for new drugs, biologics, and associated devices. FDA will also address ways to translate pharmacogenomics into medical product development and clinical practice.


'"/>




Page: 1 2

Related medicine news :

1. Adventure Enthusiasts, Risk Takers and Those Living on the Edge, Good News Coming Your Way
2. Adrenaline Associated With Adventurers Risk Taking
3. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
4. Inhaled Steroids Safe & Effective for Children with Asthma
5. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
6. Fluoride Found Effective in Osteoporosis
7. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
8. Implantable Contact Lens Found Safe and Effective
9. Effective And Economical Agent For Anthrax
10. Stem Cell Transplants May Be Effective For MS Patients
11. Effective therapy for Huntingtons disease
Post Your Comments:
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3Results of Ongoing Testing Show Air Quality is Safe Near Schools in Beaver and Erie Counties in Pennsylvania 57577 1Results of Ongoing Testing Show Air Quality is Safe Near Schools in Beaver and Erie Counties in Pennsylvania 57577 2Results of Ongoing Testing Show Air Quality is Safe Near Schools in Beaver and Erie Counties in Pennsylvania 57577 3BioCryst to Present at UBS Global Life Sciences Conference 57575 1BioCryst to Present at UBS Global Life Sciences Conference 57575 2Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 1Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 2Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 3Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 4Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 5Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 6Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 7Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 8Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 9Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 10Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 11Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 12Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 13Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 14Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 15